Share
Preview
A brighter future… built with biology
Hi ,

Just dropped! A brand new SynBioBeta podcast episode with John Cumbers and Matt Ocko! Also, join today’s Spaces show to get all your proteomics questions answered (what even is proteomics??), apply to be a speaker at SynBioBeta 2021, and more exciting news from across the built with biology community:

Be a Speaker at SynBioBeta 2021!
Click to apply to speak at our IN-PERSON conference! Apply here
Early bird tickets and hotel reservations are also on sale! Click here for more info.
Listen: Built with Biology Spaces

Join us today for the Built with Biology show on Twitter Spaces at 8 am PT! Spaces is an audio-only platform—all you need is a Twitter handle and the Twitter app on your phone.
  • Today’s guests include Parag Mallick, co-founder and Chief Scientific Officer of Nautilus

Congrats to DNA Script on officially launching the SYNTAX System, a fully integrated, automated benchtop printer that synthesizes DNA oligos using enzymes. We’re excited to see the impact that printing oligos can make, from the lab to emerging disaster areas, maybe even the next pandemic. A shout out to the entire DNA Script team! Read more.
Listen: SynBioBeta Podcast
What Will Our Technology Future Look Like? Star Trek vs Star Wars
What will the future bring, a utopian world like Star Trek or a dystopia one like Star Wars? John Cumbers talks with Matt Ocko, co-founder and co-Managing Partner of the silicon valley deep tech venture fund DCVC about how he evaluates a company in the context of these sci-fi classics. Listen to the latest SynBioBeta podcast here!
John Cumbers for Forbes
New Technology Could Unlock The Secrets Of Every Protein In The Body
Nautilus Biotechnology, a life sciences company, is unlocking the complexity of the proteome, which is the complete set of proteins expressed by an organism. Studying proteins creates opportunities to have a deeper understanding of the human body and diseases. It also makes finding the right biomarkers to detect health problems or diseases possible, so drug development is faster and more effective.
P.S. You can hear more from Parag Mallick, co-founder and CSO of Nautilus on today’s Twitter show! Click here on your phone to join!
Mapping Gene Activity In Tissues Just Got Easier And Why It Matters For Space Travel
Named the method of the year by Nature in 2020, spatialomics, also called spatially resolved transcriptomics or spatial transcriptomics, is transforming research in many areas, like cancer, neurology, and immunology. Now, 10x Genomics, a life science technology company, has announced a new way to study spatialomics in preserved tissue samples.

Biotechnology Is Replacing Petrochemicals With Identical, Sustainable Materials
Genomatica, a biology company that is remaking everyday products through clean manufacturing, announced that a second commercial plant will be powered by its technology. Through a partnership, Cargill, a global food corporation, and HELM, a family-owned distributor and chemical marketing company, will invest $300 million to build the new plant.
Science News

Funding News
  • Graphite Bio has filed to raise up to $100 million in an IPO. The money will support the development of gene editing drugs for sickle cell disease, X-linked severe combined immunodeficiency syndrome (XSCID) and Gaucher disease.
  • AbSci announced the acquisition of Totient, a company enabling cell therapies by building the largest library of human-derived antibodies.
  • Codex DNA, creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, announced the launch of its public offering of 6.7 million shares of its common stock.

Have a great week,
Regards,

Fiona Mischel
Editor in Chief, SynBioBeta
Latest news
Who's hiring?
Was it useful? Help us to improve!

With your feedback, we can improve the newsletter. Click on a link to vote:

Email Marketing by ActiveCampaign